Severe metabolic acidosis induced by 5-oxoproline accumulation after paracetamol and flucloxacillin administration
1
Department of Intensive Care Medicine, Laurentius Hospital, Roermond, Netherlands
2
Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
3
Department of Hospital Pharmacy, Laurentius Hospital, Roermond, Netherlands
4
Department of Hospital Pharmacy, VieCuri Medical Centre, Venlo, Netherlands
5
Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, Netherlands
Abstract
In this case report we present a singular case of metabolic acidosis seen in a 78-year-old female who was admitted to the intensive care unit (ICU) with dyspnoea, tachypnoea and tachycardia due to paracetamol and flucloxacillin usage. Laboratory examination revealed a high anion gap metabolic acidosis caused by accumulation of 5-oxoproline, otherwise known as pyroglutamic acid. Treatment consisted of discontinuation of the offending drugs and supportive care with sodium bicarbonate, inotropic medication and mechanical ventilation. Seven days after ICU admission, treatment was complicated by recurrence of metabolic acidosis after discontinuation of sodium bicarbonate. Our patient also developed 5-oxoproline-associated metabolic encephalopathy. We demonstrate that the elimination of 5-oxoproline will take longer than expected. Furthermore, this case clearly illustrates the potentially unexpected delayed clearance of 5-oxoproline. We also briefly discuss treatment modalities. © 2020, Netherlands Society of Intensive Care. All rights reserved.
License
Copyright (c) Netharland Journal of Critical Care
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Neth. J. Crit. Care open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.